Growth Metrics

ENDRA Life Sciences (NDRA) Operating Expenses: 2016-2021

Historic Operating Expenses for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to $3.1 million.

  • ENDRA Life Sciences' Operating Expenses rose 36.25% to $3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $11.5 million, marking a year-over-year decrease of 0.03%. This contributed to the annual value of $10.8 million for FY2024, which is 2.82% up from last year.
  • According to the latest figures from Q4 2021, ENDRA Life Sciences' Operating Expenses is $3.1 million, which was up 15.88% from $2.7 million recorded in Q3 2021.
  • ENDRA Life Sciences' 5-year Operating Expenses high stood at $3.3 million for Q3 2020, and its period low was $360,697 during Q1 2017.
  • Over the past 3 years, ENDRA Life Sciences' median Operating Expenses value was $2.8 million (recorded in 2019), while the average stood at $2.8 million.
  • In the last 5 years, ENDRA Life Sciences' Operating Expenses surged by 688.42% in 2018 and then dropped by 27.99% in 2020.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Operating Expenses stood at $2.3 million in 2017, then fell by 12.93% to $2.0 million in 2018, then soared by 56.31% to $3.1 million in 2019, then declined by 27.99% to $2.3 million in 2020, then skyrocketed by 36.25% to $3.1 million in 2021.
  • Its Operating Expenses was $3.1 million in Q4 2021, compared to $2.7 million in Q3 2021 and $3.2 million in Q2 2021.